Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma

Abstract

DCP could be a complementary biomarker in the early diagnosis of HCC. The constructed multi-marker prediction algorithms could contribute toward distinguishing HCC from non-malignant chronic liver diseases.